Cart 0 $0.00
IRE favicon


Resource ID: #20301
Subject: Pharmaceuticals
Source: Business Week
Date: 2001-07-09


BusinessWeek reports on ImClone's IMC-C225, a cancer drug awaiting FDA approval after more than 20 years and $100 million spent on research.

This file is not available for digital download. IRE members may place an order by emailing

109 Lee Hills Hall, Missouri School of Journalism   |   221 S. Eighth St., Columbia, MO 65201   |   573-882-2042   |   |   Privacy Policy
apartmentpenciluserscalendar-fullcrossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram
My cart
Your cart is empty.

Looks like you haven't made a choice yet.